Retatrutide 16mg is a synthetic incretin-mimetic peptide and triple receptor agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor signaling systems
But for many people, the early weeks come with unwanted side effects: nausea, dizziness, fatigue, and general digestive discomfort
Imaging 14 , e012174 (2021)
The NHS website provides information on weight management services, and NICE's guideline on obesity (CG189, or its current replacement) and patient decision aids can help you understand your options
Semaglutide, one of the most well-known GLP-1 medications, is available in both injectable and oral forms